26 results
8-K
LRMR
Larimar Therapeutics Inc
21 May 21
Entry into a Material Definitive Agreement
9:30am
liabilities and to pay all fees and expenses incident to the Company’s performance of or compliance with the Registration Rights Agreement.
Amended
8-K
EX-14.1
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
can be found on the Company’s internal website. An anonymous report should provide enough information about the incident or situation to allow
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
28 Jun 18
Zafgen Announces Proposed Offering of Common Stock
5:01pm
and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the costs incident to the authorization … , issuance, sale, preparation and delivery of the Shares and any taxes payable in that connection;
(ii) the costs incident to the preparation, printing
8-K
EX-10.3
4awk427d 9l9p
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
tf9anhk2
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-1.1
wld736r2sb
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
S-1
EX-10.13
p3go9pyn
18 Apr 14
IPO registration
12:00am
8-K
EX-1.1
wd46oz1
9 Nov 18
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-1.1
ec5dyo3rwu5obdoo2f7
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
8-K/A
EX-99.2
icvx7adi
26 Jun 20
Other Events
5:08pm
8-K
EX-10.1
prwvtk6 tz7yjl
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm